South Texas Accelerated Research Therapeutics, LLC (START)

San Antonio, Texas 78229

1 studies enrolling now · 6 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumors, Bile Duct Cancer, Bladder Cancer, Breast Cancer, Breast Neoplasm Malignant Primary, Carcinoma, Cervical Cancer, Cholangiocarcinoma, Colo-rectal Cancer, Colorectal Cancer, Colorectal Neoplasm

Studies at this site

• A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer — Recruiting now
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene — Completed
• A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer — Completed
• A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors — Stopped early
• Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer — Stopped early
• Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment — Completed